About the journal
Prostate Cancer and Prostatic Diseases is a journal published by Springer Nature in United Kingdom. It is listed in MEDLINE according to the sources read. Declared publication charge: 4,690 EUR. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Springer Nature
- ISSN
- 1476-5608 · 1365-7852
- Country
- United Kingdom
- Access
- Not open access / not declared
- Declared publication charge
- 4,690 EUR
- Declared peer-review model
- peer_review
- Official website
- https://www.nature.com/pcan/
Index listings
- MEDLINE · 2002-01-01
- Indexing
- MEDLINE
- APC
- 4,690 EUR
- Declared review time (DOAJ)
- —
- Actual review time (measured)
- 132 days received→accepted — computed from PubMed (n=97)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Works in OpenAlex
2586
Last recorded publication year
2026
h-index
100
i10-index
1489
From OpenAlex open data (CC0).
Editorial & policy5
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 97%
- ORCID iDs in current deposits
- 98%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
Identity & continuity3
- Alternate titles
- Prostate cancer
- Source type
- journal
- NLM unique ID (PubMed)
- 9815755
Classification(no data)
No data available to the platform for this group
No platform data for: Classification — absence is not a judgment about the journal.
Subject areas
- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Treatment and Research
- Prostate Cancer Treatment and Research
- Urinary Bladder and Prostate Research
- Urinary Bladder and Prostate Research
- Cancer, Lipids, and Metabolism
- Cancer, Lipids, and Metabolism
Show all subjects (50)
- Hormonal and reproductive studies
- Hormonal and reproductive studies
- Urologic and reproductive health conditions
- Urologic and reproductive health conditions
- Advanced Radiotherapy Techniques
- Advanced Radiotherapy Techniques
- Pelvic floor disorders treatments
- Pelvic floor disorders treatments
- Radiopharmaceutical Chemistry and Applications
- Radiopharmaceutical Chemistry and Applications
- Cancer survivorship and care
- Cancer survivorship and care
- Bone health and treatments
- Bone health and treatments
- Bladder and Urothelial Cancer Treatments
- Bladder and Urothelial Cancer Treatments
- Sexual function and dysfunction studies
- Sexual function and dysfunction studies
- Urinary Tract Infections Management
- Urinary Tract Infections Management
- Global Cancer Incidence and Screening
- Global Cancer Incidence and Screening
- MRI in cancer diagnosis
- MRI in cancer diagnosis
- Inflammatory Biomarkers in Disease Prognosis
- Inflammatory Biomarkers in Disease Prognosis
- Estrogen and related hormone effects
- Estrogen and related hormone effects
- Urological Disorders and Treatments
- Urological Disorders and Treatments
- Metabolism, Diabetes, and Cancer
- Metabolism, Diabetes, and Cancer
- Cancer Risks and Factors
- Genital Health and Disease
- Genital Health and Disease
- Cancer Risks and Factors
- Cancer Immunotherapy and Biomarkers
- Molecular Biology Techniques and Applications
- Cancer Genomics and Diagnostics
- Molecular Biology Techniques and Applications
- Cancer Immunotherapy and Biomarkers
- Cancer Genomics and Diagnostics
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ